Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial - Concepedia

Concepedia

Publication | Open Access

Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

DOI Full Paper Access

1.2K

Citations

23

References

2009

Year

Ian M. Thompson, Catherine M. Tangen, Jorge C. Paradelo, M. Scott Lucia, Gary J. Miller, Dean A. Troyer, Edward M. Messing, Jeffrey D. Forman, Joseph L. Chin, Gregory P. Swanson,

The Journal of Urology

Abstract

Adjuvant radiotherapy after radical prostatectomy for a man with pT3N0M0 prostate cancer significantly reduces the risk of metastasis and increases survival.

References

	Year	Citations
Cancer Statistics, 2008 Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward, CA A Cancer Journal for Clinicians Cancer StatisticsEpidemiologyCancer EpidemiologyMedicineEpidemiology Of Cancer	2008	10.2K
Nonparametric Estimation from Incomplete Observations Edward L. Kaplan, Paul Meier Journal of the American Statistical Association EngineeringAgingLife PredictionRare Event EstimationMortality Rates	1958	7.7K
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer Ian F. Tannock, Ronald de Wit, William R. Berry, New England Journal of Medicine	2004	5.7K
Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer Daniel P. Petrylak, Catherine M. Tangen, Maha Hussain, New England Journal of Medicine	2004	3.7K
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors Martin G. Sanda, Rodney L. Dunn, Jeff M. Michalski, New England Journal of Medicine	2008	2.2K
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer Anna Bill‐Axelson, Lars Holmberg, Mirja Ruutu, New England Journal of Medicine	2011	1.9K
Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) M. Bolla, Hendrik Van Poppel, Laurence Collette, The Lancet UrologySurgical OncologyRadiation MedicineRadiation TherapyMedicine	2005	1.1K
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer Anna Bill‐Axelson, Lars Holmberg, Mirja Ruutu, New England Journal of Medicine	2005	1.1K
Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer Ian M. Thompson, Catherine M. Tangen, Jorge C. Paradelo, JAMA	2006	892
Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy Andrew J. Stephenson, Peter T. Scardino, Michael W. Kattan, Journal of Clinical Oncology	2007	884

Page 1